BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8758483)

  • 1. TNF alpha production by whole blood from HIV-1 infected patients.
    Benyoucef S; Hober D; Shen L; Ajana F; De Groote D; Gérard Y; Lion G; Vermesch A; Bocket-Mouton L; Mouton Y; Wattré P
    Pathol Biol (Paris); 1996 May; 44(5):393-6. PubMed ID: 8758483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon and tumor necrosis factor responses of HIV+ patients as markers for monitoring of the AIDS progression.
    Piasecki E; Ledwoń TK; Inglot AD; Knysz B; Simon K; Inglot M; Gładysz A
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):439-45. PubMed ID: 8572904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of TNFalpha and IL-6 by activated whole blood from HIV-1 infected patients detected by a one-stage procedure: relationship with the phenotype of HIV-1 isolates.
    Benyoucef S; Hober D; Shen L; Ajana F; De Groote D; Bocket-Mouton L; Gérard Y; Lion G; Vilain V; Wattré P
    Microbiol Immunol; 1997; 41(12):939-46. PubMed ID: 9492179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
    J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures.
    Weber-Dabrowska B; Zimecki M; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 2000; 48(1):31-7. PubMed ID: 10722229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha mediated apoptosis of CD4 positive T-lymphocytes. A model of T-cell depletion in HIV infected individuals.
    Klein SA; Dobmeyer JM; Dobmeyer TS; Falke D; Kabelitz D; Friese K; Helm EB; Hoelzer D; Rossol-Voth R
    Eur J Med Res; 1996 Feb; 1(5):249-58. PubMed ID: 9374446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine expression during syphilis infection in HIV-1-infected individuals.
    Knudsen A; Benfield T; Kofoed K
    Sex Transm Dis; 2009 May; 36(5):300-4. PubMed ID: 19265730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte protein synthesis is increased with the progression of HIV-associated disease to AIDS.
    Caso G; Garlick PJ; Gelato MC; McNurlan MA
    Clin Sci (Lond); 2001 Dec; 101(6):583-9. PubMed ID: 11724643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily production of human tumor necrosis factor in lipopolysaccharide (LPS)-stimulated ex vivo blood culture assays.
    Aguillón JC; Escobar A; Ferreira V; Aguirre A; Ferreira L; Molina MC; Ferreira A
    Eur Cytokine Netw; 2001 Mar; 12(1):105-10. PubMed ID: 11282553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine detection in HIV-1/HHV-8 co-infected subjects.
    Pugliese A; Torre D; Saini A; Pagliano G; Gallo G; Pistono PG; Paggi GC
    Cell Biochem Funct; 2002 Sep; 20(3):191-4. PubMed ID: 12125094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: potential role in subcutaneous adipocyte apoptosis.
    Domingo P; Vidal F; Domingo JC; Veloso S; Sambeat MA; Torres F; Sirvent JJ; Vendrell J; Matias-Guiu X; Richart C;
    Eur J Clin Invest; 2005 Dec; 35(12):771-80. PubMed ID: 16313254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha and nitric oxide in vertically HIV-1-infected children: implications for pathogenesis.
    González-Nicolás J; Resino S; Jiménez JL; Alvarez S; Fresno M; Muñoz-Fernández MA
    Eur Cytokine Netw; 2001; 12(3):437-44. PubMed ID: 11566624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokines in children with immunodeficiencies].
    Kowalczyk D
    Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of in vitro ethanol on tumor necrosis factor-alpha production by blood obtained from simian immunodeficiency virus-infected rhesus macaques.
    Stoltz DA; Nelson S; Kolls JK; Zhang P; Bohm RP; Murphey-Corb M; Bagby GJ
    Alcohol Clin Exp Res; 2002 Apr; 26(4):527-34. PubMed ID: 11981130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
    Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
    Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
    Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM
    Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine profile in human immunodeficiency virus positive patients with and without tuberculosis.
    Agarwal SK; Singh A; Anuradha S; Singh NP; Sokhi J; Baveja UK
    J Assoc Physicians India; 2001 Aug; 49():799-802. PubMed ID: 11837467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interferon-gamma (IFN-gamma) based whole blood assay to detect T cell response to antigens in HIV-1 infected patients.
    Benyoucef S; Hober D; De Groote D; De La Tribonniere X; Vilain V; Lion G; Bouzidi A; Wattre P
    Pathol Biol (Paris); 1997 May; 45(5):400-3. PubMed ID: 9296092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.